Purchase Order 75N95022P00152
Award Date 3/11/22
Potential Completion Date 3/13/23
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27707, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $24,900.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a for-profit limited liability company and sole proprietorship, on July 23, 2019. The contract has a completion date of September 30, 2019 and does not have a set-aside designation. Chemogenics Biopharma, LLC is a leading company in preclinical drug discovery and has been awarded several...
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri) for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities. The purpose is to identify molecules that bind the KIAA0203 protein, which could potentially lead to the development of a new Alzheimer's drug. The contract has a period of performance from...
- This is a firm fixed price purchase order for five Chromium Next GEM Single Cell Kits awarded by the National Institute on Drug Abuse, a civilian agency under the Department of Health and Human Services, to the small business prime contractor 10X Genomics, Inc. The total award value is $59,643.04. This requirement was set aside for small businesses. The kits will be delivered to the National Institutes of Health campus in Bethesda, Maryland to support single-cell sequencing research by the Human...
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
- This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...
- This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
- The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
- This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...